Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Sales | 4,440,000 | 3,979,000 | 3,929 | 3,810 |
| Cost of Goods | 1,885,000 | 1,621,000 | 1,549 | 1,629 |
| Gross Profit | 2,555,000 | 2,358 | 2,380 | 2,181 |
| Operating Expenses | 1,946,000 | 1,682,446 | 2,293 | 2,259 |
| Operating Income | 609,000 | 675,554 | 636 | 551 |
| Interest Expense | 88,000 | 152,000 | 166 | 171 |
| Other Income | 121,000 | -421,554 | 61 | -26 |
| Pre-tax Income | 642,000 | 102,000 | 531 | 354 |
| Income Tax | 189,000 | 10,000 | 167 | 120 |
| Net Income Continuous | 649,000 | 140,352 | 616,067 | 396,425 |
| Net Income | $440,000 | $80,000 | $345 | $222 |
| EPS Basic Total Ops | 0.38 | 0.00 | N/A | N/A |
| EPS Basic Continuous Ops | 0.11 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.38 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.11 | N/A | N/A | N/A |
| EBITDA(a) | $781,000 | $675,554 | $636 | $551 |